Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Metastatic Urothelial Cancer

Urothelial Bladder Carcinoma

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Transitional Cell, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Carcinoma, Neuroendocrine

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Liposarcoma, Sarcoma

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

Rectal Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

Oligometastatic Prostate Cancer

Neoplasms, Prostatic Neoplasms

Uterine Cervical Neoplasms

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Squamous Cell Carcinoma of Head and Neck

Locally Advanced Cervical Cancer

Locally Advanced Pancreatic Cancer

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Clinical Trials

VELOCITY-Lung

TROPHY U-01

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

ARC-10

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

VELOCITY-HNSCC

EDGE-Gastric

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

REWENEC 01

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

ELEVATE HNSCC

Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

IMMUNORARE5

PANTHER

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Domvanalimab and Zimberelimab in Advanced Liver Cancers

SBRT-AMICO

Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer

Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma

A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

CZCNRHNSCC

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

CC